Skip to main content
Fig. 1 | Cancer Cell International

Fig. 1

From: Deciphering molecular mechanisms underlying chemoresistance in relapsed AML patients: towards precision medicine overcoming drug resistance

Fig. 1

Patient 1 timeline. Depiction of all treatment courses and subsequent outcomes of patient 1, showing the stages from which specimens were obtained for analysis. Abbreviations: DNR, daunorubicin; Ara-C, Cytarabine; HiDAC, high dose Ara-C; HSCT, hematopoietic stem cell transplantation; MX, mitoxantrone; VP-16, etoposide; VEN, venetoclax

Back to article page

Cancer Cell International

ISSN: 1475-2867

Contact us